{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:06:40Z","timestamp":1780682800976,"version":"3.54.1"},"reference-count":42,"publisher":"Informa UK Limited","issue":"25","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Maternal-Fetal &amp; Neonatal Medicine"],"published-print":{"date-parts":[[2022,12,12]]},"DOI":"10.1080\/14767058.2021.1940940","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T01:41:45Z","timestamp":1624326105000},"page":"8055-8061","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Pravastatin is useful for prevention of recurrent severe placenta-mediated complications \u2013 a pilot study"],"prefix":"10.1080","volume":"35","author":[{"given":"Michael J.","family":"Kupferminc","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lis Hospital for Women, Tel-Aviv Sourasky Medical Center, Tel Aviv University","place":["Tel-Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chagit","family":"Kliger","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lis Hospital for Women, Tel-Aviv Sourasky Medical Center, Tel Aviv University","place":["Tel-Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Rimon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lis Hospital for Women, Tel-Aviv Sourasky Medical Center, Tel Aviv University","place":["Tel-Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Asher-Landsberg","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lis Hospital for Women, Tel-Aviv Sourasky Medical Center, Tel Aviv University","place":["Tel-Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Skornick-Rapaport","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lis Hospital for Women, Tel-Aviv Sourasky Medical Center, Tel Aviv University","place":["Tel-Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronni","family":"Gamzu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lis Hospital for Women, Tel-Aviv Sourasky Medical Center, Tel Aviv University","place":["Tel-Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yariv","family":"Yogev","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lis Hospital for Women, Tel-Aviv Sourasky Medical Center, Tel Aviv University","place":["Tel-Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2011.09.011"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003018"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.03.006"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573396314666180712114531"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1599149"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14906"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31139-4"},{"key":"e_1_3_2_9_1","first-page":"1053","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomized controlled NOH-PE trial","volume":"106","author":"Gris JC","year":"2011","unstructured":"Gris JC, Chauleur C, Molinari N, et\u00a0al. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomized controlled NOH-PE trial. ThrombHaemost. 2011;106:1053\u20131061.","journal-title":"ThrombHaemost"},{"key":"e_1_3_2_10_1","first-page":"771","article-title":"Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial","volume":"104","author":"Gris JC","year":"2010","unstructured":"Gris JC, Chauleur C, Faillie JL, et\u00a0al. Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial. ThrombHaemost. 2010;104:771\u2013779.","journal-title":"ThrombHaemost"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/10641950600745517"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-02-0169"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000509662"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080763"},{"issue":"4","key":"e_1_3_2_15_1","first-page":"614","article-title":"Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience","volume":"80","author":"Branch DW","year":"1992","unstructured":"Branch DW, Silver RM, Blackwell JL, et\u00a0al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992;80(4):614\u2013620.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001673"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013663"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e10ebd"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011293108"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.175919"},{"key":"e_1_3_2_21_1","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/FactorVIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipidsyndrome","volume":"118","author":"Redecha P","year":"2008","unstructured":"Redecha P, Franzke CW, Ruf W, et\u00a0al. Neutrophil activation by the tissue factor\/FactorVIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipidsyndrome. J Clin Invest. 2008;118:3453\u20133461.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2015.1022864"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008229"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.12.038"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05445"},{"key":"e_1_3_2_26_1","first-page":"15","article-title":"Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies","volume":"124","author":"Girardi G.","year":"2017","unstructured":"Girardi G. Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies. J ReprodImmunol. 2017;124:15\u201320.","journal-title":"J ReprodImmunol"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000522"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713651"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86957"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.05.038"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1035"},{"key":"e_1_3_2_32_1","first-page":"1122","article-title":"Hypertension in pregnancy report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","author":"American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.","year":"2013","unstructured":"American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. ObstetGynecol. 2013;122:1122\u20131131.","journal-title":"ObstetGynecol"},{"issue":"5","key":"e_1_3_2_33_1","first-page":"311","article-title":"Birth weight standards in the live-born population in Israel","volume":"7","author":"Dollberg S","year":"2005","unstructured":"Dollberg S, Haklai Z, Mimouni FB, et\u00a0al. Birth weight standards in the live-born population in Israel. Isr Med Assoc J. 2005;7(5):311\u2013314.","journal-title":"Isr Med Assoc J"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68397-9"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.5.625"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4250"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03230.x"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.11.565"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2016.1196185"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1879785"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16013"}],"container-title":["The Journal of Maternal-Fetal &amp; Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14767058.2021.1940940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:52:46Z","timestamp":1780681966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14767058.2021.1940940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":42,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2022,12,12]]}},"alternative-id":["10.1080\/14767058.2021.1940940"],"URL":"https:\/\/doi.org\/10.1080\/14767058.2021.1940940","relation":{},"ISSN":["1476-7058","1476-4954"],"issn-type":[{"value":"1476-7058","type":"print"},{"value":"1476-4954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijmf20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijmf20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}